Orris

One patient is having ankle fracture for that he was prescribed fabcal in whic the vit d3 dose is 2000iu and he was also prescribed uprise d3 once a week in which dose of vit d3 is 60 k iu is, is this safe to give this amount of vit d3?

Reading File
Finding Sources
Finding Sources
Searching PubMed

"vitamin D" supplementation "fracture" safety toxicity upper limit

Reading File
Finding Sources
Searching PubMed

"vitamin D" supplementation safety "upper tolerable" OR "tolerable upper"

Searching the Web

Fabcal composition vitamin D3 2000 IU calcium India + Uprise D3 60000 IU weekly safe co-prescribing

Finding Sources
Now I have enough information to give a thorough, evidence-based answer. Here it is:

Vitamin D3 Safety Assessment: Fabcal (2000 IU/day) + Uprise-D3 (60,000 IU/week)

What the Patient Is Receiving

MedicationDoseFrequencyWeekly Total
Fabcal (Calcium + Vit D3)2000 IUDaily14,000 IU
Uprise-D3 60K60,000 IUOnce weekly60,000 IU
Combined weekly total~74,000 IU/week (~10,571 IU/day equivalent)

Is This Safe? - A Balanced Assessment

The short answer: It is likely safe short-term but the combination requires clinical justification

1. Established upper limits from authoritative sources:
  • The Tolerable Upper Intake Level (UL) is set at 4000 IU/day by the U.S. National Academy of Sciences (Harrison's Principles of Internal Medicine, 22nd Ed.)
  • Fitzpatrick's Dermatology notes that 10,000 IU/day is considered a safe upper limit for adults in some references
  • The combined regimen in this patient gives an average equivalent of ~10,571 IU/day, which sits right at or just above the 10,000 IU/day safety ceiling
2. The 60,000 IU weekly dose (Uprise-D3) is standard practice in India:
  • 60,000 IU once weekly is a widely used and clinically validated loading/maintenance regimen in India for vitamin D deficiency, supported by multiple Indian studies
  • Harrison's specifically notes: "Vitamin D deficiency can be treated by oral administration of 50,000 IU/week for 6-8 weeks followed by a maintenance dose of 800 IU/d"
  • A large Indian retrospective study of 8,685 patients receiving 60,000 IU weekly for up to 12 weeks showed no adverse events in 98.1% of patients, with only mild transient effects in 1.6%
3. The problem is the overlap - both are being given simultaneously:
  • Fabcal (2000 IU/day) is a maintenance/supplementation product - typically given for ongoing bone support
  • Uprise-D3 60K is a loading/treatment dose for documented deficiency
  • Giving both together without checking baseline 25(OH)D levels means the patient could receive the loading dose on top of an already adequate or borderline level
4. Risk of Vitamin D Toxicity: According to Harrison's, acute vitamin D toxicity - though rare - is:
  • Characterised by hypercalcemia and high 1,25(OH)2 vitamin D levels
  • Most commonly caused by uncontrolled or excessive supplement use
  • Requires discontinuation of supplements and management of hypercalcemia
At ~74,000 IU/week, the risk is low but non-negligible, especially if:
  • The patient has underlying hypercalcemia, sarcoidosis, lymphoma, or granulomatous disease
  • The patient is on thiazide diuretics (which reduce calcium excretion)
  • The patient has reduced renal function (common in elderly fracture patients)
  • The patient is also consuming calcium-fortified foods or additional calcium supplements

Clinical Recommendation

The co-prescription can be justified if the patient has confirmed vitamin D deficiency, but the following steps are advisable:
  1. Check baseline 25(OH)D levels before or shortly after starting both medications. If levels are already >30 ng/mL, the 60,000 IU weekly loading is unnecessary and should be stopped.
  2. Short-term use only - the Uprise-D3 60K should typically be given for 8-12 weeks as a loading course, not indefinitely alongside a daily supplement.
  3. After completing the Uprise-D3 course, continue only Fabcal (daily maintenance).
  4. Monitor serum calcium and 25(OH)D at 8-12 weeks to ensure levels are not exceeding 100 ng/mL.
  5. Assess for risk factors for toxicity: renal disease, granulomatous conditions, concurrent thiazide use.

Bottom Line

Prescribing both simultaneously is not inherently dangerous for a short course (8-12 weeks) in a vitamin D-deficient patient with an ankle fracture, especially since bone healing has genuine vitamin D requirements. However, it is better practice to either:
  • Use only Uprise-D3 60K weekly as the loading dose, then switch to Fabcal for maintenance, OR
  • Check 25(OH)D levels first and prescribe the loading dose only if there is documented deficiency
The prescriber should be aware of the combined weekly total (~74,000 IU) and ensure the loading course is time-limited. Monitoring is the key safety measure.
Sources: Harrison's Principles of Internal Medicine 22E (2025); Fitzpatrick's Dermatology; Indian retrospective study (8,685 patients) on 60,000 IU weekly supplementation; Safety and Efficacy of Loading Doses of Vitamin D (MDPI Pharmaceuticals)

How much vit d3 daily supplement level is safe

Finding Sources
Finding Sources
Your credits are exhausted. You can purchase a top-up or subscribe to a plan to continue using Orris. If you're already subscribed, your daily credits will reset tomorrow.

Provide me the source in which daily safe level of vit d3 is given

Your credits are exhausted. You can purchase a top-up or subscribe to a plan to continue using Orris. If you're already subscribed, your daily credits will reset tomorrow.
This is a shared conversation. Sign in to Orris to start your own chat.